Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the MYO15A gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
The documentation surrounding autosomal recessive nonsyndromic hearing loss 3 is limited due to its rarity and the recent identification of the MYO15A gene as its genetic basis. Conditions like this often lack systematic clinical studies, leading to gaps in understanding the full spectrum of clinical features and management strategies. This can be frustrating, but ongoing research may provide clearer insights in the future.
To navigate your care effectively, consider consulting with an audiologist who specializes in genetic hearing loss. Genetic counseling can also be beneficial, especially given the known involvement of the MYO15A gene. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials may provide valuable insights and support. While there are currently no patient organizations identified, connecting with broader hearing loss communities may offer additional resources and support.
Currently, there is one active clinical trial related to autosomal recessive nonsyndromic hearing loss 3. You can explore this trial further at ClinicalTrials.gov by searching for the condition. While there are no orphan drug designations at this time, participation in clinical trials may provide access to innovative therapies and contribute to the understanding of this condition.
Actionable guidance for navigating care for autosomal recessive nonsyndromic hearing loss 3
To navigate your care effectively, consider consulting with an audiologist who specializes in genetic hearing loss. Genetic counseling can also be beneficial, especially given the known involvement of the MYO15A gene. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials may provide valuable insights and support. While there are currently no patient organizations identified, connecting with broader hearing loss communities may offer additional resources and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.